| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/08/2001 | CN1306981A Polypeptide-4Fe-4S redox protein 9 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306980A Polypeptide-RGS protein 17 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306979A Polypeptide-robosomal protein L20, 16 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306977A Polypeptide-hexapetalous duplicon 20 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306975A Polypeptide-leucine multiple repeat sequence 71 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306973A Polypeptide-Sl RNA combining area 27 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306972A Polypeptide-TBC area 32 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306971A Polypeptide-sugar transport protein 47 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306970A Polypeptide-F-cassette structural protein 65 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306969A Polypeptide-GTP enzyme Rho family active site 90 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306966A Polypeptide-human zinc finger protein 30 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306965A Bacteriocidal/permeation enhanced protein functional area bioactive pipetide |
| 08/08/2001 | CN1306858A Hemoglobin polymerizing agent |
| 08/08/2001 | CN1069316C Substituted 5-ring heterocycles, their preparation and use |
| 08/08/2001 | CN1069215C Antihypoxic formulation |
| 08/08/2001 | CN1069214C Stabilized somatotropin for parenteral administration |
| 08/08/2001 | CN1069213C Hemopoietic forebody cell protective agent |
| 08/07/2001 | US6271442 Nucleotide sequences coding protein for use in the development of disease resistant plants and animals; for use in the treatment of disease in animals and plants |
| 08/07/2001 | US6271393 Process for producing N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271367 Nucleotide sequences coding modulator of enzymatic activity; for use in the modulation of blood coagulation |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271364 Nucleotide sequences coding polypeptide associated with nerve growth factor; for the treatment of diabetes, amyotrophic lateral sclerosis, and thrombocytopenia |
| 08/07/2001 | US6271363 Nucleotide sequences coding morphology determining polypeptides; for diagnosis and treatment of cell proliferation and differentiation defects; for treatment of urogenital and osteogenic defects |
| 08/07/2001 | US6271359 Genetically engineered vector coding antisense agents; for use in killing preferential target cells or microrganisms |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271351 Method for preserving a hemoglobin blood substitute |
| 08/07/2001 | US6271349 Polypeptide; for use in controlling immune response; for detecting modulators of gene expression |
| 08/07/2001 | US6271347 Eosinophil eotaxin receptor |
| 08/07/2001 | US6271346 TNF Receptors, TNF binding proteins and DNAs coding for them |
| 08/07/2001 | US6271344 Enhanced affinity hyaluronan binding peptides |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271211 Muscle contraction |
| 08/07/2001 | US6271210 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer |
| 08/07/2001 | US6271207 Enhanced expression of transgenes |
| 08/07/2001 | US6271205 Neurological tumor in mammals |
| 08/07/2001 | US6271204 Activation of pyruvate dehydrogenase phosphatase |
| 08/07/2001 | US6271203 Anti-protozoan methods and materials |
| 08/07/2001 | US6271202 Administering neuropeptide |
| 08/07/2001 | US6271201 Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271199 Treatment of infarcts |
| 08/07/2001 | US6271198 Constrained helical peptides and methods of making same |
| 08/07/2001 | US6271197 Administering a geranylgeranyl transferase inhibitor |
| 08/07/2001 | US6271196 Polypeptide |
| 08/07/2001 | US6271030 For modulation of c/ebp beta (transcription factor enhancer-binding gene) expression and for treatment of diseases associated with expression of c/ebp beta |
| 08/07/2001 | US6271029 Antisense inhibition of cytohesin-2 expression |
| 08/07/2001 | US6271026 Nucleotide sequences coding protein associated with vision defects; for the diagnsis and treatment of preferential vision defects |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6271015 A polypeptide having an amino acid sequence that hydrolysizes cis-9,10-octadecenoamide and other soporific fatty acid amides; therapy for sleep disorders and narcolepsy |
| 08/07/2001 | US6270999 A streptococcal polynucleotide encoding a polypeptide of the lysyl trna synthetase family; diagnosis and therapy of otitis media, conjunctivitis, pneumonia, meningitis, sinusitis; screening antibiotics |
| 08/07/2001 | US6270998 An isolated nucleic acid involved in apoptosis; diagnosis and therapy of diseases associated with human immunodeficiency virus; antitumor agents |
| 08/07/2001 | US6270995 A polypeptide that regulate nerve cell function and morphology; diagnosis and therapy for nervous system disorders |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270991 A polynucleotide encoding an amino acid sequence; diagnosis and therapy for streptococcal infections; treatment of otitis media, conjunctivitis, pneumonia, meningitis, and sinusitis |
| 08/07/2001 | US6270989 A homologous recombinant dna construct comprising a targeting sequence, an exogenous regulatory sequence, an exon and an unpaired splice donor site at the 3'end; gene therapy for thrombopoietin, thrombocytopenia, multiple sclerosis |
| 08/07/2001 | US6270984 Modulating robo: ligand interactions |
| 08/07/2001 | US6270979 Screening for modulators of preferential recptor activity; incubate cells and narcotic analgesic and monitor receptor activity in the presence and absence of modulator |
| 08/07/2001 | US6270978 Immunomethods for isolating and indentifying human influx peptide transporter |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270957 Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection |
| 08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
| 08/07/2001 | US6270955 Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus |
| 08/07/2001 | US6270793 Hydratable keratin solid wherein said hydratable keratin comprises keratin having sulfonic acid groups ionically associated with monovalent cations. |
| 08/07/2001 | US6270791 Soluble keratin peptide |
| 08/07/2001 | US6270781 Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270775 Streptococcal C5a peptidase vaccine |
| 08/07/2001 | US6270772 Mhc class ii based molecules that comprise covalently linked beta 1 and alpha 1 domains, and mhc class i based molecules that comprise covalently linked alpha 1 and alpha 2 domains. |
| 08/07/2001 | US6270766 Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| 08/07/2001 | US6270765 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 08/07/2001 | US6270764 Therapy for a serious and debilitating disorder while avoiding complications such as bleeding tendency, toxicity and general side effects of currently available anti-coagulant agents. |
| 08/07/2001 | US6270763 Recombinant products are useful for diagnosis of allergy and for therapeutic treatment of allergy. |
| 08/07/2001 | US6270762 Relates to polynucleotides and polypeptides of the thymidylate kinase family, as well as their variants. |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | US6270757 Formulations for IL-11 |
| 08/07/2001 | US6270756 Weight loss induced by alpha interferon and gamma interferon |
| 08/07/2001 | US6270755 Anionic polymers as toxin binders |
| 08/07/2001 | CA2222613C A device for delivering a preselected molecule into systemic circulation |
| 08/07/2001 | CA2191101C Materials and methods for treatment of plaquing diseases |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2092919C Epoxysuccinamic acid derivatives |
| 08/07/2001 | CA2075718C Crf analogs |
| 08/07/2001 | CA2044746C Polypeptide compound and a process for preparation thereof |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055725A2 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | WO2001055449A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055448A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055447A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055442A2 Novel bone marrow nucleic acids and polypeptides |
| 08/02/2001 | WO2001055440A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055439A1 Compositions and methods for inhibition of hiv-1 infection |
| 08/02/2001 | WO2001055437A2 Novel nucleic acids and polypeptides |
| 08/02/2001 | WO2001055431A1 A novel polypeptide, a human glucosamine-6-phosphoric acid isomerase 12 and the polynucleotide encoding the polypeptide |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055426A1 Novel polypeptide---human zinc-finger protein 43 containing tfiis characteristic sequence fragment and polynucleotide encoding it |